Medical comms - Press Releases

Date	Title	Company
12-Mar-2020	Vifor Pharma Group reports strong growth in 2019, exceeding raised guidance	Vifor Pharma Group
12-Mar-2020	Acacia Pharma Announces Brief Extension of FDA Review Period for NDA for BYFAVO™, an Ultra-short Acting and Reversible Anesthetic for Procedural Sedation	Acacia Pharma Group plc
12-Mar-2020	Zelluna Immunotherapy collaborates with Karolinska Institutet and enters into the NextGenNK Competence Center for allogeneic TCR based Natural Killer cell (TCR-NK) therapy development	Zelluna Immunotherapy
12-Mar-2020	Major R&D milestones achieved in 2019 and strong clinical activity in 2020	Transgene
12-Mar-2020	Data visualisation tools developed by Zegami will be used by Oxford University for large cardiovascular clinical trials	Zegami
12-Mar-2020	New study published in the Journal of Antimicrobial Chemotherapy-Antimicrobial Resistance shows benefit of cystitis service in community pharmacies	Boots UK
11-Mar-2020	Bone Therapeutics announces 2019 full year results	Bone Therapeutics
11-Mar-2020	Tiziana Life Sciences plc To Expedite Development of its Fully Human Anti-Interleukin-6-Receptor Monoclonal Antibody, a Potential Treatment of Certain Patients Infected with Coronavirus COVID-19	Tiziana Life Sciences plc
11-Mar-2020	BillionToOne has raised more than $32.5 million. The funding will be used to support the commercial expansion of UNITY™ to all US states	BillionToOne
11-Mar-2020	First mental health trust joins collaboration of North East NHS organisations to drive forward digital health technology within the region	Health Call
11-Mar-2020	Drugs alone cannot improve diabetes patients’ outcomes	GlobalData
11-Mar-2020	Overcoming Data Collection and System Challenges in Real World Studies, Upcoming Webinar Presented Byr Cmed	Cmed Clinical Research Services
10-Mar-2020	PharmiWeb Launches New Job Board for Pharma & Life Sciences in Australasia	PharmiWeb
10-Mar-2020	Freeline receives Orphan Drug Designation from the European Commission for FLT190 for the treatment of Fabry Disease	Freeline
10-Mar-2020	PureTech Affiliate Gelesis Named One of the World’s Most Innovative Companies for 2020 by Fast Company	PureTech
10-Mar-2020	Orgenesis Year-End Results, outlines business model and POCare strategy post-Masthercell sale	Orgenesis
10-Mar-2020	Pivotal Acquires Akcelis, an Industry Leader in Patient Engagement, Recruitment and Retention	Pivotal
10-Mar-2020	Positive results from Phase IIb field study of FLU-v vaccine (FLU-v 003), which has been developed by Imutex Limited, hVIVO's 49% joint venture with the SEEK Group. FLU-v is a first-in-class ‘universal’, broad spectrum, standalone, influenza vaccine candidate and the results have now been published in a peer review journal	Open Orphan plc
10-Mar-2020	Locust Walk Appointed Strategic and Business Development Advisor for the Licensing Process of ILB™	TIKOMED
10-Mar-2020	Immutep receives second IND approval for Efti from US FDA	Immutep Limited